Cargando…

The utility of the Brief Edinburgh Depression Scale (BEDS) in assessing severity of depression in advanced cancer patients

AIMS: When using an assessment tool, brevity and validity are essential. Although brief depression inventories exist, they rely heavily on the inclusion of somatic symptoms. This can be problematic in advanced cancer populations; weight loss and sleep disturbance are for the most part ubiquitous in...

Descripción completa

Detalles Bibliográficos
Autores principales: Meyer, Zeryab, Shiels, Christopher, Dowrick, Christopher, Lloyd-Williams, Mari
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8771818/
http://dx.doi.org/10.1192/bjo.2021.161
_version_ 1784635697958748160
author Meyer, Zeryab
Shiels, Christopher
Dowrick, Christopher
Lloyd-Williams, Mari
author_facet Meyer, Zeryab
Shiels, Christopher
Dowrick, Christopher
Lloyd-Williams, Mari
author_sort Meyer, Zeryab
collection PubMed
description AIMS: When using an assessment tool, brevity and validity are essential. Although brief depression inventories exist, they rely heavily on the inclusion of somatic symptoms. This can be problematic in advanced cancer populations; weight loss and sleep disturbance are for the most part ubiquitous in these patients and may not necessarily be indicative of depression. The Brief Edinburgh Depression Scale (BEDS) is a 6-item shortened version of the Edinburgh Depression Scale which has been validated for use in patients with advanced cancer and is used internationally. The BEDS cut off threshold of 6/18 indicates that depression may be present. However, the BEDS currently provides no information regarding severity. The aim of this study is to establish severity thresholds for the BEDS by comparing it to another depression scale: the commonly used, rigorously validated, Patient Health Questionnaire (PHQ-9). METHOD: 284 advanced cancer patients attending hospice day services in the North West of England completed both the PHQ-9 and the BEDS. Mean participant age was 66.7 (Standard Deviation = 13.2) and the sample contained both males (n = 102, 36%) and females (n = 182, 64%). BEDS severity thresholds with the highest Sensitivity (Sn) and Specificity (Sp) were selected based on their ability to predict PHQ-9 categories. RESULT: A BEDS score of 4 to 6 was selected to indicate ‘mild depression’ (Sn = 81.7, Sp = 65); 7 to 8 ‘moderate depression’ (Sn = 74.8, Sp = 78.7); 9 to 11 ‘moderately severe depression’ (Sn = 82, Sp = 82.9) and 12 or more ‘severe depression’ (Sn = 63.2, Sp = 92.8). A linearly weighted kappa (with s weighting) showed a moderate level of agreement (0.47, 95% Confidence Interval: 0.40-0.54). CONCLUSION: The BEDS is a simple and brief tool used to screen for depression in advanced cancer patients. It is administered throughout the UK and multiple translation studies have enabled its global a (including in resource poor countries). The severity thresholds calculated here are derived from a large sample of patients with advanced cancer attending hospice services and demonstrate acceptable sensitivity and specificity in relation to the PHQ-9, a thoroughly validated reference standard. We conclude that the generated BEDS thresholds support use of the BEDS in determining the presence and severity of depression in advanced cancer populations.
format Online
Article
Text
id pubmed-8771818
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Cambridge University Press
record_format MEDLINE/PubMed
spelling pubmed-87718182022-01-31 The utility of the Brief Edinburgh Depression Scale (BEDS) in assessing severity of depression in advanced cancer patients Meyer, Zeryab Shiels, Christopher Dowrick, Christopher Lloyd-Williams, Mari BJPsych Open Rapid-Fire Poster Presentations AIMS: When using an assessment tool, brevity and validity are essential. Although brief depression inventories exist, they rely heavily on the inclusion of somatic symptoms. This can be problematic in advanced cancer populations; weight loss and sleep disturbance are for the most part ubiquitous in these patients and may not necessarily be indicative of depression. The Brief Edinburgh Depression Scale (BEDS) is a 6-item shortened version of the Edinburgh Depression Scale which has been validated for use in patients with advanced cancer and is used internationally. The BEDS cut off threshold of 6/18 indicates that depression may be present. However, the BEDS currently provides no information regarding severity. The aim of this study is to establish severity thresholds for the BEDS by comparing it to another depression scale: the commonly used, rigorously validated, Patient Health Questionnaire (PHQ-9). METHOD: 284 advanced cancer patients attending hospice day services in the North West of England completed both the PHQ-9 and the BEDS. Mean participant age was 66.7 (Standard Deviation = 13.2) and the sample contained both males (n = 102, 36%) and females (n = 182, 64%). BEDS severity thresholds with the highest Sensitivity (Sn) and Specificity (Sp) were selected based on their ability to predict PHQ-9 categories. RESULT: A BEDS score of 4 to 6 was selected to indicate ‘mild depression’ (Sn = 81.7, Sp = 65); 7 to 8 ‘moderate depression’ (Sn = 74.8, Sp = 78.7); 9 to 11 ‘moderately severe depression’ (Sn = 82, Sp = 82.9) and 12 or more ‘severe depression’ (Sn = 63.2, Sp = 92.8). A linearly weighted kappa (with s weighting) showed a moderate level of agreement (0.47, 95% Confidence Interval: 0.40-0.54). CONCLUSION: The BEDS is a simple and brief tool used to screen for depression in advanced cancer patients. It is administered throughout the UK and multiple translation studies have enabled its global a (including in resource poor countries). The severity thresholds calculated here are derived from a large sample of patients with advanced cancer attending hospice services and demonstrate acceptable sensitivity and specificity in relation to the PHQ-9, a thoroughly validated reference standard. We conclude that the generated BEDS thresholds support use of the BEDS in determining the presence and severity of depression in advanced cancer populations. Cambridge University Press 2021-06-18 /pmc/articles/PMC8771818/ http://dx.doi.org/10.1192/bjo.2021.161 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Rapid-Fire Poster Presentations
Meyer, Zeryab
Shiels, Christopher
Dowrick, Christopher
Lloyd-Williams, Mari
The utility of the Brief Edinburgh Depression Scale (BEDS) in assessing severity of depression in advanced cancer patients
title The utility of the Brief Edinburgh Depression Scale (BEDS) in assessing severity of depression in advanced cancer patients
title_full The utility of the Brief Edinburgh Depression Scale (BEDS) in assessing severity of depression in advanced cancer patients
title_fullStr The utility of the Brief Edinburgh Depression Scale (BEDS) in assessing severity of depression in advanced cancer patients
title_full_unstemmed The utility of the Brief Edinburgh Depression Scale (BEDS) in assessing severity of depression in advanced cancer patients
title_short The utility of the Brief Edinburgh Depression Scale (BEDS) in assessing severity of depression in advanced cancer patients
title_sort utility of the brief edinburgh depression scale (beds) in assessing severity of depression in advanced cancer patients
topic Rapid-Fire Poster Presentations
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8771818/
http://dx.doi.org/10.1192/bjo.2021.161
work_keys_str_mv AT meyerzeryab theutilityofthebriefedinburghdepressionscalebedsinassessingseverityofdepressioninadvancedcancerpatients
AT shielschristopher theutilityofthebriefedinburghdepressionscalebedsinassessingseverityofdepressioninadvancedcancerpatients
AT dowrickchristopher theutilityofthebriefedinburghdepressionscalebedsinassessingseverityofdepressioninadvancedcancerpatients
AT lloydwilliamsmari theutilityofthebriefedinburghdepressionscalebedsinassessingseverityofdepressioninadvancedcancerpatients
AT meyerzeryab utilityofthebriefedinburghdepressionscalebedsinassessingseverityofdepressioninadvancedcancerpatients
AT shielschristopher utilityofthebriefedinburghdepressionscalebedsinassessingseverityofdepressioninadvancedcancerpatients
AT dowrickchristopher utilityofthebriefedinburghdepressionscalebedsinassessingseverityofdepressioninadvancedcancerpatients
AT lloydwilliamsmari utilityofthebriefedinburghdepressionscalebedsinassessingseverityofdepressioninadvancedcancerpatients